Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 692,188	$ 1,137,303
Trade accounts receivable, less allowance for doubtful accounts (2018 – $10,098; 2017 – $10,425)	606,968	534,326
Other accounts receivable	43,410	37,937
Inventories	666,567	592,781
Other current assets	113,763	136,064
Assets held for sale	35,829	39,152
Total current assets	2,158,725	2,477,563
Property, plant and equipment, at cost	4,247,345	4,124,335
Less accumulated depreciation and amortization	1,678,139	1,631,025
Net property, plant and equipment	2,569,206	2,493,310
Investments	524,687	534,064
Noncurrent assets held for sale	151,743	139,813
Other assets	78,619	74,164
Goodwill	1,643,746	1,610,355
Other intangibles, net of amortization	429,614	421,503
Total assets	7,556,340	7,750,772
Current liabilities:
Accounts payable	481,726	418,537
Accrued expenses	262,883	268,336
Current portion of long-term debt	39,216	422,012
Dividends payable	36,885	35,165
Liabilities held for sale	2,173	1,938
Income taxes payable	45,977	54,937
Total current liabilities	868,860	1,200,925
Long-term debt	1,436,852	1,415,360
Postretirement benefits	52,090	52,003
Pension benefits	296,671	294,611
Noncurrent liabilities held for sale	682	614
Other noncurrent liabilities	588,640	599,174
Deferred income taxes	369,115	370,389
Commitments and contingencies (Note 10)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 110,756 in 2018 and 110,547 in 2017	1,107	1,105
Additional paid-in capital	1,855,321	1,863,949
Accumulated other comprehensive loss	(174,739)	(225,668)
Retained earnings	2,118,621	2,035,163
Total Albemarle Corporation shareholders’ equity	3,800,310	3,674,549
Noncontrolling interests	143,120	143,147
Total equity	3,943,430	3,817,696
Total liabilities and equity	$ 7,556,340	$ 7,750,772